Search Results - Patrick F. Smith
- Showing 1 - 5 results of 5
-
1
Optimizing COVID‐19 Candidate Therapeutics: Thinking Without Borders by Craig R. Rayner, Patrick F. Smith, Kevin Hershberger, David Wesche
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study by David Kallend, Jay Mason, Patrick F. Smith, Michael J. Koren, Robert Stoekenbroek, YanLing He, Peter Wijngaard
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants by Sibel Ucpinar, Patrick F. Smith, Li Long, Fujun Li, Hui Yan, Jyoti Wadhwa, Katherine A. Chu, Jin Shu, Philip Nunn, Mengyao Li
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjects by Sibel Ucpinar, Borje Darpo, Ann Neale, Philip Nunn, Jin Shu, Katherine A. Chu, Marianne Kavanagh, Hongqi Xue, Pasit Phiasivongsa, Dolca Thomas, Patrick F. Smith
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168) by Timothy D. Owens, Patrick F. Smith, Andrew Redfern, Yan Xing, Jin Shu, Dane E. Karr, Sonja Hartmann, Michelle R. Francesco, Claire L. Langrish, Philip A. Nunn, Steven G. Gourlay
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book